Comments
Loading...

Forte Biosciences

FBRXNASDAQ
Logo brought to you by Benzinga Data
$7.85
1.1216.64%
Pre-Market: Aug 30, 4:59 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$4.00
Lowest Price Target1
$2.75
Consensus Price Target1
$3.31

Forte Biosciences (NASDAQ:FBRX) Stock, Analyst Ratings, Price Targets, Forecasts

Forte Biosciences Inc has a consensus price target of $3.31 based on the ratings of 4 analysts. The high is $4 issued by Brookline Capital on May 30, 2024. The low is $2.75 issued by Ladenburg Thalmann on April 8, 2024. The 3 most-recent analyst ratings were released by Chardan Capital, Brookline Capital, and Ladenburg Thalmann on August 19, 2024, May 30, 2024, and April 8, 2024, respectively. With an average price target of $3.25 between Chardan Capital, Brookline Capital, and Ladenburg Thalmann, there's an implied -58.60% downside for Forte Biosciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Chardan Capital
Brookline Capital
Ladenburg Thalmann
Chardan Capital

1calculated from analyst ratings

Analyst Ratings for Forte Biosciences

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Forte Biosciences (FBRX) stock?

A

The latest price target for Forte Biosciences (NASDAQ:FBRX) was reported by Chardan Capital on August 19, 2024. The analyst firm set a price target for $3.00 expecting FBRX to fall to within 12 months (a possible -61.78% downside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Forte Biosciences (FBRX)?

A

The latest analyst rating for Forte Biosciences (NASDAQ:FBRX) was provided by Chardan Capital, and Forte Biosciences maintained their buy rating.

Q

When was the last upgrade for Forte Biosciences (FBRX)?

A

The last upgrade for Forte Biosciences Inc happened on April 8, 2024 when Ladenburg Thalmann raised their price target to $2.75. Ladenburg Thalmann previously had a neutral for Forte Biosciences Inc.

Q

When was the last downgrade for Forte Biosciences (FBRX)?

A

There is no last downgrade for Forte Biosciences.

Q

When is the next analyst rating going to be posted or updated for Forte Biosciences (FBRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Forte Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Forte Biosciences was filed on August 19, 2024 so you should expect the next rating to be made available sometime around August 19, 2025.

Q

Is the Analyst Rating Forte Biosciences (FBRX) correct?

A

While ratings are subjective and will change, the latest Forte Biosciences (FBRX) rating was a maintained with a price target of $3.00 to $3.00. The current price Forte Biosciences (FBRX) is trading at is $7.85, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch